Lakefront Biotherapeutics NV

Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics

14 Oct 2026 16:01:00 Источник Nasdaq GlobeNewswire

Acquisition of Own Shares

13 Oct 2026 16:01:00 Источник Nasdaq GlobeNewswire

Lakefront Receives Transparency Notification from Bank of America

08 Oct 2026 16:01:00 Источник Nasdaq GlobeNewswire

Acquisition of Own Shares

06 Oct 2026 16:01:00 Источник Nasdaq GlobeNewswire

Acquisition of Own Shares

29 Sep 2026 16:01:00 Источник Nasdaq GlobeNewswire

Acquisition of Own Shares

22 Sep 2026 16:01:00 Источник Nasdaq GlobeNewswire

Acquisition of Own Shares

15 Sep 2026 16:01:00 Источник Nasdaq GlobeNewswire

Acquisition of Own Shares

08 Sep 2026 16:02:00 Источник Nasdaq GlobeNewswire

Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

08 Sep 2026 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities

05 Jan 2026 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus

18 Dec 2025 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025

08 Dec 2025 01:30:00 Источник Nasdaq GlobeNewswire

Galapagos Receives Transparency Notifications from Bank of America

26 Nov 2025 01:30:00 Источник Nasdaq GlobeNewswire

Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update

05 Nov 2025 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos to Present New Data from Cell Therapy Program at ASH 2025

03 Nov 2025 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development

30 Oct 2025 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors

23 Oct 2025 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

21 Oct 2025 01:30:00 Источник Nasdaq GlobeNewswire

Galapagos Announces Appointment of Fred Blakeslee as General Counsel

16 Oct 2025 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business  

01 Oct 2025 16:01:00 Источник Nasdaq GlobeNewswire